Severe Acute Respiratory Syndrome Coronavirus 2-Specific Monoclonal Antibody for the Treatment of Mild to Moderate Coronavirus Disease 2019 in Cancer Patients: A Single-Center Experience.

Autor: Puing AG; Division of Infectious Diseases, Department of Medicine, City of Hope National Medical Center, Duarte, California, USA., Ho S; Department of Pharmacy Services, City of Hope National Medical Center, Duarte, California, USA., Frankel P; Division of Biostatistics, Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, California, USA., Tegtmeier B; Division of Infectious Diseases, Department of Medicine, City of Hope National Medical Center, Duarte, California, USA., Martin A; Division of Infectious Diseases, Department of Medicine, City of Hope National Medical Center, Duarte, California, USA., Ross J; Department of Pharmacy Services, City of Hope National Medical Center, Duarte, California, USA., Nanayakkara D; Division of Infectious Diseases, Department of Medicine, City of Hope National Medical Center, Duarte, California, USA., Dickter J; Division of Infectious Diseases, Department of Medicine, City of Hope National Medical Center, Duarte, California, USA., Seto T; Department of Quality, Risk and Regulatory Management, City of Hope National Medical Center, Duarte, California, USA., Nakamura R; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Taplitz R; Division of Infectious Diseases, Department of Medicine, City of Hope National Medical Center, Duarte, California, USA., Dadwal S; Division of Infectious Diseases, Department of Medicine, City of Hope National Medical Center, Duarte, California, USA.
Jazyk: angličtina
Zdroj: The Journal of infectious diseases [J Infect Dis] 2022 Jan 18; Vol. 225 (2), pp. 352-354.
DOI: 10.1093/infdis/jiab406
Databáze: MEDLINE